San Francisco
-
Startups, Medical Devices, Health Tech
Digital physical therapy company Hinge Health expands into pain relief
The digital physical therapy company acquired a startup making a small, adhesive device that use electrical pulses for pain treatment.
-
Satsuma Pharma rounds up $80M to give its migraine treatment another shot
Satsuma Pharmaceuticals executives say they now understand why their intranasal migraine treatment failed a pivotal test. But even with a new Phase 3 plan, the company is behind a competitor that could launch its intranasal migraine treatment later this year.
-
A status report on healthcare’s adoption of digital documents
The Covid-19 pandemic has given a new sense of urgency for healthcare organizations to shift parts of their business that rely on paper-based documents to digital documents. That’s just one of the findings of a survey of healthcare organizations in a new report.
-
GSK commits $345M to Vir as alliance expands to flu, other respiratory viruses
The amended pact follows a collaboration begun last year when GlaxoSmithKline paid Vir Biotechnology $250 million to team up on potential treatments for Covid-19. The expansion includes an influenza treatment based on Vir’s antibody technology.
-
Verana strikes research collaboration with Janssen on ophthalmology and urology
Data analytics startup Verana Health struck a partnership with Janssen Research & Development. They’ll focus on exploring better treatments for diabetic retinopathy and macular edema.
-
Carbon Health raises $100M to expand its network of clinics
Carbon Health, which more than tripled its footprint in the last year, plans to further grow its network of primary care and urgent care clinics with $100 million in new funding.
-
Health Services, Startups, SYN
Honor raises $140M to grow home-care network
Honor, a San Francisco-based startup that strikes partnerships with home care companies, raised $140 million in a series D round. The company helps manage back-office functions in exchange for a portion of their revenue.
-
Clover Health goes public in $3.7B SPAC deal
Medicare Advantage startup Clover Health will go public in a blank-check acquisition led by billionaire Chamath Palihapitiya. The deal will value Clover at $3.7 billion.
-
Startups, Employee Benefits, Health Services
Grand Rounds raises $175M
The San Francisco-based startup, whose clients include Walmart and the Home Depot, plans to use the funds to offer more virtual primary care services.
-
Vir, GSK launch late-stage clinical trial of monoclonal antibody for Covid-19 virus
The companies said Monday that they had launched the Phase II/III COMET-ICE trial of VIR-7831, which will enroll about 1,300 patients around the world and investigate the drug as a way to prevent hospitalization of high-risk individuals infected with SARS-CoV-2.
-
Expand your virtual care potential with deviceless remote patient monitoring
Examine the 3 major challenges associated with device-based remote patient monitoring and learn how a deviceless strategy can overcome them.
-
Startups, Health Services, Telemedicine
Mental health coaching startup Ginger raises $50M
Ginger, a startup that provides mental health coaching services to its members, raised $50 million in series D funding.
-
Events, Health IT, Health Services, Startups, SYN
INVEST Pitch Perfect winner spotlight: Luma Health keeps patients connected between visits
Patient engagement platform Luma Health was designed to help patients schedule appointment with the doctor without having to wait months. With Covid-19, the startup’s vision has expanded.
-
Artificial Intelligence, BioPharma
Roche, PicnicHealth start RWD partnership with multiple sclerosis focus
The companies will use a combination of more than seven years of medical record data with five years of prospective data on 5,000 MS patients, including real-world outcomes data and MRI images. Other disease areas to be explored include hematology and rare diseases.
-
Startups, Telemedicine, Health Services
‘Telegenomics’ startup Genome Medical raises another $14M
Genome Medical, a startup that provides telehealth genetic consultations, raised a $14 million extension for its $23 million series B round.
-
After filing for IPO, ArcherDX agrees to $1.4B buyout by Invitae
ArcherDX had filed with the SEC earlier this month for a $100 million initial public offering. The two companies said combining would enable cancer patients to access a variety of testing products and services from one source.
-
Alnylam, Vir aim for year-end FDA filing to start Covid-19 antiviral drug trial
The companies said Monday they had identified the first candidate for clinical trials, a direct-acting antiviral RNA-interference drug that they plan to develop as an inhaled therapy against the SARS-CoV-2 virus.



